期刊
CLINICAL LUNG CANCER
卷 22, 期 1, 页码 E112-E115出版社
CIG MEDIA GROUP, LP
DOI: 10.1016/j.cllc.2020.09.005
关键词
Molecularly targeted therapy; Gefitinib; NSCLC; Precision oncology; TKI
类别
资金
- Hungarian Innovation Agency [NVKP_16-1-2016-0005, KFI_16-1-2016-0048, 2019-1.1.1-PIACI-KFI-2019-00367]
分享论文
